Chinook Therapeutics (NASDAQ: KDNY)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Chinook Therapeutics (NASDAQ: KDNY) through any online brokerage.
The latest price target for Chinook Therapeutics (NASDAQ: KDNY) was reported by SVB Leerink on Monday, May 23, 2022. The analyst firm set a price target for 44.00 expecting KDNY to rise to within 12 months (a possible 191.20% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Chinook Therapeutics (NASDAQ: KDNY) is $15.11 last updated May 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Chinook Therapeutics.
Chinook Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Chinook Therapeutics.
Chinook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.